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Activation of Pak by membrane localization mediated by an SH3
domain from the adaptor protein Nck
Wange Lu, Steve Katz, Ruchika Gupta and Bruce J. Mayer
Background: The adaptor protein Nck consists of three Src homology 3 (SH3)
domains followed by one SH2 domain. Like the Grb2 adaptor protein, which is
known to couple receptor tyrosine kinases to the activation of the small GTPase
Ras, Nck is presumed to bind to tyrosine-phosphorylated proteins using its SH2
domain and to downstream effector proteins using its SH3 domain. Little is
known, however, about the specific biological function of Nck. The Pak family of
serine/threonine kinases are known to be activated by binding to the GTP-bound
form of Cdc42 or Rac1, which are small GTPases of the Rho family that are
involved in regulating the organization of the actin cytoskeleton. 
Results: We present evidence that Nck can mediate the relocalization and
subsequent activation of the Pak1 kinase. We show that Nck associates in vivo
with Pak using the second of its three SH3 domains, and that localization of this
individual Nck SH3 domain, or of Pak kinase itself, to the membrane results in
activation of Pak and stimulation of downstream mitogen activated protein kinase
cascades. Activation of downstream signaling by the membrane-localized Nck
SH3 domain is blocked by a kinase-inactive mutant form of Pak1. 
Conclusion: These results demonstrate that localization of Pak1 to the
membrane in the absence of other signals is sufficient for its activation, and imply
that the Nck adaptor protein could function to link changes in tyrosine
phosphorylation of cellular proteins to the Cdc42/Pak signaling pathway.
Introduction
The controlled formation of protein complexes is a central
theme in eukaryotic signal transduction. Signal-induced
changes in protein–protein associations serve to relocalize
proteins within the cell and to modulate their activities. Src
homology 2 and 3 (SH2 and SH3) domains, which are small,
modular domains found in a wide variety of proteins impli-
cated in signaling, frequently mediate protein–protein
interactions in signal transduction (reviewed in [1,2]). SH2
domains bind with high affinity to tyrosine-phosphorylated
proteins [3,4], whereas SH3 domains bind to proline-rich
peptides. Individual SH2 and SH3 domains also have indi-
vidual binding specificities —  different domains bind with
highest affinity to different spectra of ligands — although it
is clear that, to some extent, the specificities of different
SH2 or SH3 domains overlap [5–8].
SH2/SH3 adaptor proteins consist almost entirely of SH2
and SH3 domains, and lack intrinsic enzymatic activity,
suggesting that they serve to couple upstream tyrosine-
phosphorylated signaling molecules, bound by the SH2
domains, to downstream SH3-binding effectors [1,2]. The
prototype adaptor protein is Grb2 [9]; genetic studies have
implicated Grb2 in signaling pathways involved in vulva
development in Caenorhabditis elegans and eye development
in Drosophila. In each system, the adaptor protein was
shown to function downstream of a receptor tyrosine kinase
and upstream of the small GTP-binding protein Ras
[10–12]. Biochemical studies have shown that Grb2 binds
via its two SH3 domains to a proline-rich region of Sos, a
guanine-nucleotide exchange factor for Ras. Therefore,
activation of a tyrosine kinase generates binding sites for
the Grb2 SH2 domain, and Grb2 then uses its SH3 domains
to bring Sos to the plasma membrane, where Sos can
activate its substrate, Ras, which is also localized at the
membrane (reviewed in [13]).
The SH2/SH3 adaptor protein Nck consists of three SH3
domains followed by one SH2 domain [14]. Nck is
expressed in a wide range of tissues and cell lines, and is
phosphorylated on serine, threonine and tyrosine residues
following stimulation of cells with growth factors [15–17].
Overexpression of Nck can lead to transformation of
fibroblasts [15,18], and can also inhibit the neural differen-
tiation of PC12 cells in a way that is independent of the
mitogen activated protein kinase (MAP kinase) pathway
[19]. We have shown previously that dominant-negative
Nck mutants could not block the Ras-dependent activa-
tion of the MAP kinase Erk1 (extracellular receptor-
activated kinase 1) in experiments in which similar
mutants of Crk, another adaptor protein, and of Grb2 were
able to block Erk1 activation, suggesting that Nck might
Address:  Howard Hughes Medical Institute,
Children’s Hospital and Department of
Microbiology and Molecular Genetics, Harvard
Medical School, 320 Longwood Avenue, Boston,
Massachusetts 02115, USA.
Correspondence:  Bruce J. Mayer
E-mail:  bmayer@rascal.med.harvard.edu
Received:  4 November 1996
Revised: 9 December 1996
Accepted:  19 December 1996
Published: 16 January 1997
Electronic identifier: 0960-9822-007-00085
Current Biology 1997, 7:85–94
© Current Biology Ltd ISSN 0960-9822
Research Paper 85
have a different function from Grb2 and Crk [20]. In
Drosophila, an Nck homolog was shown to be involved in
axon guidance and targeting in photoreceptor cells [21],
but the molecular mechanisms involved are still not clear.
It has been shown that the SH2 domain of Nck binds the
receptor for platelet-derived growth factor (PDGF), the
insulin receptor substrate-1 (IRS-1), Src and focal adhesion
kinase (FAK) [18,22–24]. The SH3 domains of Nck have
been shown to associate with a number of proteins includ-
ing Sos [25], c-Cbl [26], a 65kDa serine/threonine kinase
termed NAK [27], the Wiskott–Aldrich syndrome protein
WASP [28] and PRK2, a serine/threonine kinase closely
related to the putative Rho effector protein kinase N
(PKN) [29]. Recently, two groups have also suggested that
Nck links receptor tyrosine kinases to Pak1, a member of
the Pak family of serine/threonine kinases [30,31].
However, a role for any of these proteins in the biological
activity of Nck has yet to be demonstrated.
Here, we present evidence for a biologically relevant
association between Nck and Pak1. The family of Pak
serine/threonine kinases can be directly activated by the
Rho-family GTPases Cdc42 and Rac1 [32–34], which reg-
ulate the organization of the actin cytoskeleton [35]. We
show that Pak and Nck are associated in vivo, and that this
association can be abolished by a single point mutation in
the second SH3 domain of Nck. Membrane localization of
either the second SH3 domain of Nck, or of Pak1 itself,
led to the stimulation of Pak kinase activity and to activa-
tion of downstream MAP kinases, including Erk1. The
activation of Erk1 by membrane-localized Nck could be
stimulated by wild-type Pak1 and blocked by kinase-inac-
tive Pak1. These data strongly suggest that the subcellular
localization of Pak has important consequences in terms of
its own activity and its ability to activate downstream sig-
naling pathways, and point to Nck as a likely mediator of
Pak relocalization in vivo. 
Results and discussion
In order to identify potential downstream effectors of Nck,
the individual SH3 domains of Nck were fused to glu-
tathione S-transferase (GST) and used to probe cytoplas-
mic extracts made from Xenopus embryos at the gastrula
stage. These extracts were initially chosen because they
are a rich source of concentrated cytoplasm, and because
Nck mRNA is highly expressed specifically during early
Xenopus development (M. Tanaka, W.L., R.G. and B.J.M.,
unpublished observations). A combination of solution
binding and filter-binding experiments consistently identi-
fied proteins of 68kDa and 55kDa that bound to the
second and third SH3 domains of Nck. In situ phosphoryla-
tion assays demonstrated that a 68kDa protein specifically
bound by the second SH3 domain of Nck had kinase activ-
ity (data not shown), consistent with data of Chou et al.
[27], who had previously shown that a 68kDa protein
kinase associated with Nck in rat cell lysates.
Pak kinases are ~65–68 kDa and contain several potential
SH3-binding motifs in their amino termini [36], suggest-
ing that the Nck-associated kinase might be a member of
this family. To test whether Nck could bind Pak, proteins
from frog cell extracts that bound to the SH3 domains of
Nck were assayed for kinase activity in the presence of
GTPgS-loaded Rho-family GTPases produced in bacteria
[32,33]. GTPgS-loaded Cdc42 and Rac1, but not RhoA,
dramatically stimulated the activity of the kinase bound
to the SH3 domains of Nck (Fig. 1a). This activity was
specifically associated with the second SH3 domain of
Nck (Fig. 1b). These results demonstrate that a protein in
Xenopus extracts that binds to the second SH3 domain of
Nck has the properties of a Pak family kinase. This is
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Figure 1
Identification of a Pak kinase as a Nck SH3 domain-binding protein.
(a) Activation of a Nck-associated kinase by GTPgS-loaded Cdc42
and Rac1. Xenopus gastrula lysates were incubated with GST, or with
GST fused to the second Nck SH3 domain (SH3-2), and bound
proteins were subjected to an in vitro kinase assay, in the presence of
Rho-family GTPases loaded with either GDP or GTPgS. The arrow
indicates position of a 65–68 kDa autophosphorylated doublet band.
(b) Pak kinase is associated only with the second SH3 domain of Nck.
In vitro kinase activity from Xenopus lysates bound by first, second,
and third SH3 domains of Nck, assayed in the presence of GTPgS-
loaded Cdc42. The arrow indicates a 65–68 kDa doublet.
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consistent with recent data showing that Nck can bind to
overexpressed Pak3 [37] and Pak1 [30,31].
Further experiments to confirm the association of Nck
with Pak and to evaluate its biological significance were
performed in human 293T cells, because of the ease of
protein expression by transient transfection and the avail-
ability of reagents for mammalian Pak and Nck. Human
Pak1 tagged with the Myc epitope co-immunoprecipitated
with Nck in lysates from cotransfected 293T cells
(Fig. 2a), strongly suggesting that a Nck–Pak1 complex
exists in vivo. The association between Pak1 and Nck was
almost completely abolished in cells expressing an Nck
protein containing a single point mutation that impairs the
ligand-binding ability of the second SH3 domain (Nck
K143). In vitro kinase assays in the presence and absence
of GTP-loaded Cdc42 were also performed on anti-Nck
immunoprecipitates from these transfected cell lysates
(Fig. 2b, bottom panel and Fig. 2c). In cells transfected
with wild-type Nck, an endogenous Pak activity coprecip-
itated with Nck (Fig. 2b, lane 3). This Nck-associated Pak
kinase activity was increased six-fold by cotransfection of
tagged Pak1 (lane 5), and was decreased to background
levels by cotransfection of a kinase-inactive version of
Pak1 (lane 7), which would be expected to compete away
binding of endogenous Pak. By contrast, in cells trans-
fected with the Nck K143 mutant, very little endogenous
or exogenous Pak activity coprecipitated with Nck (lanes
4 and 6). Immunoblotting with a Pak-specific polyclonal
antiserum confirmed the presence of both the endogenous
and the slower-migrating Myc-tagged Pak proteins in the
appropriate lanes (Fig. 2b, top panel). 
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Figure 2
Pak is associated with Nck in vivo. (a) Cells were transfected with
EBB vector alone, or plasmids expressing wild-type Nck, Nck with a
point mutation in the second SH3 domain (Nck K143), or Myc-
epitope-tagged Pak1, as indicated. Nck proteins were
immunoprecipitated with polyclonal anti-Nck antibody, and the Pak1
associated with Nck was detected by immunoblotting with anti-Myc
antibody (left panel). Pak1 expression was confirmed by
immunoprecipitation and immunoblotting with anti-Myc antibody (right
panel). (b) Pak1 kinase activity is associated with Nck in transfected
cells. 293T cells were transfected with wild-type Nck, Nck K143, or
Myc-tagged wild-type or kinase-inactive mutant (K299R) Pak, as
indicated, and anti-Nck immunoprecipitates were split and aliquots
immunoblotted with anti-Pak antibody (top) or anti-Nck antibody
(middle). Nck-associated Pak kinase activity was detected by in vitro
kinase assay with myelin basic protein (MBP) as substrate in the
absence or presence of GTPgS-loaded Cdc42 as activator (bottom).
The anti-Pak antibody recognizes both endogenous Pak and slower-
migrating Myc-tagged Pak1; the lower band in lanes 5 and 7 is likely
to contain both endogenous Pak and a comigrating degradation
product of Myc-tagged Pak1. The identity of the phosphoprotein of
about 85 kDa seen above the Pak band in in vitro kinase assays is
unknown. Positions of molecular mass markers (in kDa) are given to
the left of the bottom panel. (c) Quantification of the kinase activity as
shown in (b); values given are activity in the presence of
GTPgS–Cdc42 minus activity in its absence.
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We could also demonstrate association of endogenous Nck
and Pak in murine NIH 3T3 fibroblasts by co-immunopre-
cipitation (Fig. 3a). Although the proportion of total Nck
and Pak that could be coprecipitated was low, it was clearly
detectable. The association of endogenous Pak and Nck
was further confirmed by detection of GTP–Cdc42-stimu-
lated kinase activity in anti-Nck immunoprecipitates (Fig.
3b). This demonstrates that, in at least some cell types,
endogenous Nck and Pak exist in a preformed complex.
Because the biological role of Nck is currently unknown,
it is impossible to assess the significance of the Nck–Pak
association directly. We therefore designed experiments
based on general models of the function of SH2/SH3
adaptor proteins, to test its significance indirectly. By
analogy to Grb2, we surmised that the SH2 domain of Nck
would bind to tyrosine-phosphorylated sites and induce
relocalization of Nck-associated proteins in response to
changes in tyrosine phosphorylation. The Nck SH2
domain has been shown to bind membrane-associated
proteins, such as the growth factor receptors IRS-1 and
FAK [18,22–24]. To mimic binding of full-length Nck to
such targets, we therefore fused the second, Pak-binding
SH3 domain of Nck (SH3-2) to either the Src myristoyla-
tion signal [38,39], or the focal adhesion target (FAT)
domain of FAK [40,41]. These fusion proteins are
expected to be constitutively targeted to membranes and
focal adhesions, respectively, whereas the unfused SH3 is
expected to be cytosolic.
We first examined the biochemical consequences of
relocalization of Nck and Pak. We considered that relocal-
ization of Pak could affect its activity in at least two ways:
first, relocalization could lead to activation of Pak by
altering its accessibility to GTP-bound Cdc42, Rac or other
activators; second, it could affect its accessibility to poten-
tial downstream substrates. Pak1 was cotransfected into
293T cells with the wild-type Nck SH3-2 domain, myris-
toylated Nck SH3-2 (Src–SH3-2), or myristoylated SH3-2
containing a point mutation that eliminates ligand binding
(Src–SH3-2 K143; see Fig. 4). The specific kinase activity
of Pak1 (in the absence of exogenous Cdc42) was increased
6–10-fold in cells expressing the myristoylated Nck SH3
domain (lane 3), relative to those expressing the unmyris-
toylated SH3 domain (lane 2) or the myristoylated SH3
domain mutant (lane 4), suggesting that recruitment of
Pak1 to the membrane mediated by the myristoylated SH3
domain of Nck leads to Pak1 activation. The inability of
the unmyristoylated SH3-2 to activate Pak1 demonstrates
that SH3 binding itself is insufficient for Pak1 activation.
In order to confirm that Pak1 activation was not due to
indirect effects of expression of myristoylated SH3-2, we
used a Pak1 mutant (P13A) with a single amino-acid
change in the first proline-rich region which results in
impaired binding to the SH3 domain of Nck [30]. Unlike
wild-type Pak, the P13A mutant was not significantly acti-
vated in cells expressing the myristoylated SH3-2 domain
(Fig. 4, lane 7). Nevertheless, the P13A mutant had the
same in vitro kinase activity as wild-type Pak1 in the
absence or presence of GTP-loaded Cdc42 when isolated
from cells not expressing myristoylated SH3-2 (Fig. 4,
lanes 1 and 5 of bottom panels). This strongly suggests that
activation of Pak by myristoylated SH3-2 involves direct
association of Pak and Nck, and is not an indirect effect of
expression of the myristoylated SH3. To confirm that
membrane localization of Pak is sufficient for its activation,
we made a Pak construct in which the Src myristoylation
signal is directly fused to the amino terminus of Pak1.
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Figure 3
Endogenous Nck and Pak constitutively associate in NIH 3T3 cells.
(a) Anti-Nck and anti-Pak1 immunoprecipitates along with the
appropriate nonspecific antibody controls were split and subjected to
immunoblotting with anti-Pak and anti-Nck antibodies (upper and lower
panels respectively). (b) Pak kinase activity in immunoprecipitates
shown in panel (a) was determined by in vitro kinase assay, in the
absence or presence of GTPgS-loaded Cdc42. Results are expressed
as activity in presence of GTPgS–Cdc42 minus activity in its absence.
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Myristoylated Pak1 from transfected 293T cells had
approximately three-fold higher in vitro kinase activity in
the absence of GTP-loaded Cdc42 than did the wild-type
protein (Fig. 5). As has been seen with other Src myristoy-
lation signal fusion proteins, the Src–SH3-2 and Src–Pak
fusion proteins were found entirely in the P100 membrane
fraction of cells after hypotonic lysis (data not shown). In
contrast to the results with myristoylated SH3-2, expres-
sion of the FAT–SH3-2 fusion did not result in activation
of Pak (data not shown).
We also consistently observed that 293T cells transfected
with the myristoylated SH3-2 domain became round and
nonadherent, whereas cells transfected with the soluble
SH3 construct were indistinguishable from vector-trans-
fected controls. In agreement with the assumption that
these morphological changes were caused by targeting of
Pak to the membrane, expression of Pak1 fused to the Src
myristoylation signal also induced rounding of 293T cells,
whereas overexpression of the unmodified Pak1 did not
(data not shown). The morphological changes suggest that
constitutively targeting Pak to the membrane has
biological effects.
In order to assess more quantitatively the downstream
effects of Nck-mediated Pak relocalization, we examined
the activation of downstream signaling kinases. MAP
kinase cascades encompass three distinct but intercon-
nected pathways that result in the activation of three
kinase families: the Erk, c-Jun N-terminal kinase/stress-
activated kinases (JNK/SAPK) and the p38 kinases [42].
To test whether these specific signal transduction path-
ways are activated upon Pak1 relocalization, GST–Erk1,
GST–SAPKb and GST–p38 were each introduced into
293T cells as cotransfections with the various Nck SH3-2
and Pak constructs. GST fusion proteins were subse-
quently isolated from transfected cell lysates and sub-
jected to in vitro kinase assay. As expected, myristoylated
Nck SH3-2 led to activation of p38, whereas the unmyris-
toylated domain did not (Fig. 6a), consistent with data
from other groups showing that Pak1 is upstream of p38
[43,44]. JNK/SAPK was activated to a lesser extent (data
not shown). More surprisingly, expression of myristoylated
Nck SH3-2 resulted in approximately five-fold activation
of GST–Erk (Fig. 6b, lane 4), whereas the soluble or
FAT–fused SH3 domain did not (lanes 2 and 3), consis-
tent with the inability of these constructs to activate Pak.
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Figure 4
Activation of Pak1 by membrane-associated
Nck SH3 domain. Lysates of 293T cells
cotransfected with Myc-tagged wild-type
Pak1 or P13A Pak1, and EBB vector,
unmyristoylated Nck SH3-2, myristoylated
SH3-2 (Src–SH3-2), or myristoylated mutant
SH3-2 domain (Src–SH3-2 K143) were
immunoprecipitated with anti-Myc antibody.
Immunoprecipitates were subjected to
immunoblotting to detect Pak protein levels
(middle panel), and to in vitro kinase assays to
determine Pak activity (bottom panel). Total
lysate was immunoblotted with anti-HA
antibody to determine the relative expression
level of tagged Nck SH3-2 domains (top
panel). Right panels: activities of wild-type and
P13A mutant Pak were also compared in
presence of GTPgS–Cdc42. 
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Because the activation of Erk was unexpected, we tested
whether the activation of Erk upon expression of
myristoylated Nck SH3 was consistent with its being a
consequence of relocalization of Pak to the membrane
(Fig. 6b,c). Overexpression of wild-type Pak1 alone was
sufficient to activate Erk moderately in this system (lane
5), but expression of the myristoylated Pak1 resulted in
two-fold stronger activation than wild-type Pak (lane 6).
The activation of Erk induced by overexpression of wild-
type Pak was augmented by the presence of the myris-
toylated Nck SH3, which would direct Pak to the
membrane (lane 8), and inhibited to basal levels by the
unmodified SH3 domain, which would sequester Pak in
the cytosol (lane 7). Finally, the activation of Erk by
myristoylated Nck SH3 could be blocked by overexpres-
sion of kinase-inactive Pak1 (Fig. 6d). Taken together,
these results strongly suggest that the recruitment of
Pak1 to the membrane is sufficient for its own activation
and for activation of the Erk signaling pathway, and that
Pak1 activity is necessary for the activation of Erk by
membrane-localized Nck. 
We have shown here that the Nck adaptor protein and Pak
kinase can associate in vivo, and that alteration of the sub-
cellular localization either of the Nck SH3 domain or of
Pak itself has dramatic effects on downstream signals. We
therefore propose that the activity of Pak kinases can be
regulated by the relocalization of Nck in response to tyro-
sine phosphorylation. Although this model has some simi-
larities to the model for the activation of Raf by p21 Ras, it
is not directly analogous. In the Ras–Raf pathway, the
Grb2 adaptor protein mediates the activation of Ras in
response to tyrosine phosphorylation, and the activated
Ras then serves as a high-affinity binding site for Raf at
the membrane. Although relocalization results in Raf acti-
vation, binding of Ras is not thought to activate Raf
directly [13]. Pak kinases, in contrast, are activated
directly by GTP-loaded Cdc42 or Rac in vitro ([32–34] and
this work). We have shown here, however, that
membrane-targeted Pak1 is activated in the absence of
stimulation of Rho-family GTPases, implying that the
availability of GTP-loaded Rac or Cdc42 is not limiting for
Pak activation at 293T cell membranes.
Although Nck has already been shown to be recruited to
some receptor tyrosine kinases in the membrane, it is not
yet clear what signals stimulate Nck-mediated Pak
activation. Recently, two groups have presented evidence
suggesting that Nck couples the epidermal growth factor
(EGF) and PDGF receptor tyrosine kinases to Pak1
[30,31]. Although Pak1 can be activated to some extent by
growth factors such as PDGF and EGF [30,31], we have
found that the activation of Pak1 in EGF- or PDGF-
stimulated 293 cells could not be blocked by dominant-
negative Nck mutants (W.L. and B.J.M, unpublished
observations), casting doubt on the requirement for Nck
in these specific cases. The upstream signals involved in
Nck-mediated activation of Pak are currently under active
investigation.
We found that relocalization of Pak to the membrane led
to activation of the Erk pathway, although our experi-
ments do not address to what extent Erk activation is a
direct effect. The result was somewhat surprising, as Pak
has previously been implicated in activation of the stress-
activated p38 and JNK/SAPK pathways [43–47]. We
suspect that the specific downstream pathways activated
by Pak might depend on its subcellular localization,
because different substrates might be available to the
activated Pak in different compartments.
Experiments suggesting that JNK/SAPK and p38 are
more responsive than Erk to Pak activity have generally
involved overexpression of constitutively-active or
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Figure 5
Direct targeting of Pak1 to the membrane leads to its activation.
Constructs expressing HA-tagged wild-type or kinase-inactive mutant
Pak, with or without amino-terminal Src myristoylation signal, were
transfected into 293T cells, and lysates were immunoprecipitated with
anti-HA antibody. Immunoprecipitates were split and aliquots
subjected to immunoblotting to detect Pak protein levels (top panel),
and to in vitro kinase assays to determine Pak activity (bottom panel).
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dominant-negative Pak (or Rho-family GTPases) [43–49].
In interpreting these experiments, we must consider that
the subcellular localization of constitutively-activated Pak
is likely to be different from that of Pak activated by
normal signals, when its localization might be very
restricted. Dominant-negative experiments must also be
interpreted with caution until the specific mechanism of
inhibition — that is, what proteins are being sequestered
— is known. In our experiments, Pak is specifically acti-
vated by membrane targeting in the absence of other stim-
ulatory or inhibitory signals, so the downstream effects are
likely to be due solely to Pak activity. 
In addition to our work, other evidence for the involve-
ment of Rho-family GTPases in the Erk pathway is begin-
ning to accumulate. For example, a dominant-negative
version of Rac1 was found to block v-Abl-induced tran-
scriptional activation via the tetra-phorbol acetate (TPA)
response element (TRE) and serum response element
(SRE) enhancers, and also compromised v-Abl-induced
activation of Erk2 [50]. Work from the Cobb group [44]
also showed that expression of dominant-negative Rac1 or
the amino terminus of Pak1 could inhibit the Ras-medi-
ated activation of Erk2, and that constitutively-activated
Cdc42, Rac and Rho synergized with activated Raf to
increase Erk2 activity.
It is also becoming clear that the signaling pathways
activated by Rho-family GTPases and Pak can vary in
different cells and in different experimental systems. For
example, studies with Cdc42 and Rac1 mutants showed a
strong correlation between Pak activation and JNK
activation by Cdc42 and Rac1 [51], whereas another group
recently showed that MLK3, and not Pak1, mediated JNK
activation by activated Cdc42 [52]. In addition, although it
is generally well accepted that Cdc42 and Rac1, but not
Rho A, activate JNK kinases [48,49], Gutkind and
colleagues [53] recently showed that, while Cdc42 and Rac1
activated the JNK pathway in Cos-7 cells, as expected, in
293T cells, Cdc42 and RhoA, but not Rac1, activated JNK.
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Figure 6
Pak1 is downstream of the Nck SH3 domain
in activation of the Erk signaling pathway.
(a) The p38 kinase is activated by membrane-
associated Nck SH3-2. Plasmid expressing
GST–p38 was cotransfected with the plasmid
indicated above each lane into 293T cells.
GST–p38 was purified from lysates and equal
amounts subjected to in vitro kinase assay;
activity was measured by phosphorylation of
MBP. (b) Erk1 is activated by membrane-
associated Nck and Pak1. Plasmid expressing
GST–Erk1 was cotransfected with the
constructs labeled above into 293T cells and
GST–Erk kinase activity was determined as in
(a). As a positive control, one dish was treated
with epidermal growth factor (EGF) to activate
GST–Erk. (c) Whole cell lysates were
subjected to immunoblotting to determine the
expression levels of different constructs. All
the individual SH3 domains were HA-tagged,
except the FAT–SH3-2 construct, which was
untagged. The Pak1 cotransfected with SH3
domains in lane 7 and 8 was Myc-tagged.
Positions of molecular mass markers (in kDa)
are given to left. (d) Dominant-negative Pak1
blocks the activation of Erk induced by
membrane-localized Nck SH3 domain.
GST–Erk1 was cotransfected with
myristoylated SH3-2, with or without kinase-
inactive Pak1 mutant; 24 h after transfection,
GST–Erk was isolated and in vitro kinase
activity assayed.
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Irrespective of whether Erk is a major effector of Nck
and Pak in all cases, our experiments demonstrate that
Nck, and perhaps other SH3-containing Pak-binding
proteins, is likely to couple tyrosine kinase-mediated sig-
naling pathways to those regulated by Rho-family
GTPases.
Conclusions
Pak kinases are of considerable interest because they
have been shown to be directly activated by Rho family
GTPases, which have in turn been implicated in regulat-
ing the organization of the actin cytoskeleton. The Rho-
family GTPases and Pak kinases have also been
implicated in the activation of stress-activated MAP
kinase signaling cascades. It is still unclear, however,
what role Pak plays in normal cellular signals. We have
found that membrane localization of Pak1, either by
direct fusion to a myristoylation signal or by relocaliza-
tion mediated by binding to an SH3 domain of the Nck
adaptor protein, is sufficient to stimulate its kinase activ-
ity and activate downstream MAP kinase cascades. Pak
relocalization by means of association with Nck provides
a straightforward mechanism for coupling the activation
of Pak to extracellular signals involving tyrosine phos-
phorylation (Fig. 7). The observation that membrane
localization is sufficient to activate Pak in the absence of
other signals or activators implies that subcellular local-
ization, and not the availability of GTP-loaded Rho-
family GTPases, can limit the activation state of Pak in
growing cells.
Materials and methods 
SH3 binding and kinase assays in Xenopus lysates
Individual SH3 domains of Nck were generated by polymerase chain
reaction (PCR) from human Nck cDNA, cleaved with BamHI and
NotI, and inserted into pGEX-2N to make bacterial GST fusion con-
structs. GST–SH3-1 contains Nck residues 1–63, SH3-2 residues
106–166 and SH3-3 residues 189–257. Fusion proteins were
expressed and purified from bacteria as described [54]. 
Early gastrula-stage Xenopus embryos were collected and washed
three times with PBS followed by lysis in TXB buffer (10 mM Tris
pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 % glycerol, 1 mM sodium
orthovanadate, 1 % Triton X-100 plus protease inhibitors). Yolk pro-
teins and insoluble material were removed by centrifugation. Embryo
lysate containing 2 mg protein in a volume of 200 m l was added to
10mg of GST fusion proteins bound to 10 m l of gluta-
thione–sepharose (Pharmacia) and rotated at 4 °C for 30 min fol-
lowed by three washes with TXB. Washed beads were subjected to
in vitro kinase assay in 50 mM Hepes pH 7.5, 10 mM MgCl2, 100mM
ATP and 10mCi g-[32P ]ATP for 10 min at 30 °C, in the presence of
2mg of GTPgS- or GDP-loaded Cdc42, Rac1 and RhoA prepared as
described [32]. Reaction products were separated by SDS–poly-
acrylamide gel electrophoresis (SDS–PAGE), and gels were fixed
and exposed for autoradiography.
Constructs for mammalian cell expression
Amino-terminally Myc-tagged wild-type, P13A, and K299R human
Pak1 clones were kindly provided by J. Chernoff. The K299R muta-
tion is in the ATP-binding site and inactivates the kinase [43]. The
construction of the W143K Nck mutant (termed K143 here) has
been described [20]. Oligonucleotides encoding the influenza virus
hemagglutinin (HA) epitope tag [55] were synthesized and sub-
cloned into the Asp718 and NotI site of pEBB [20] to make pEBB-
HA. For the unmyristoylated clones, SH3-2 or Pak1 were subcloned
by PCR into the BamHI and Asp718 sites of pEBB-HA. SH3-2 con-
sists of residues 100–169 of the human Nck protein and HA-Pak1
contains the full-length human gene. For the myristoylated clones, the
14 amino-acid v-Src myristoylation signal was first synthesized by
PCR with a BglII site at the 5′ end and BamHI and Asp718 sites at
the 3′ end. The PCR product was digested with BglII and Asp718
and then cloned into the BamHI and Asp718 sites of pEBB-HA to
make pEBB-SrcHA. SH3-2 and Pak1 were then cloned into pEBB-
SrcHA. The FAT site consists of the carboxy-terminal 200 amino
acids of chicken FAK. It was subcloned by PCR into the Asp718 and
NotI sites of HA-tagged pEBB-SH3-2 replacing the HA tag.
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Figure 7
A model for Nck-mediated Pak activation. In
an unstimulated cell (left), Nck is constitutively
associated with Pak via the second SH3
domain of Nck. Upon stimulation (right),
tyrosine phosphorylated sites are generated at
the membrane, which bind to the SH2 domain
of Nck. Nck-associated Pak is activated at the
membrane by GTP-loaded Cdc42 or Rac, or
by a hypothetical GTPase-independent
mechanism. Activated Pak at the membrane
generates downstream signals, including
activation of MAP kinase cascades.
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Mammalian cell transfection, immunoprecipitation and in vitro
kinase assay
Transfection of 293T cells followed the calcium phosphate method as
described [20]. The cells were lysed 48 h later in 1 ml TXB per 10 cm
dish. Monoclonal or affinity-purified polyclonal antibody (1mg) or crude
rabbit serum (5m l) was incubated with 200m l cell lysate for 2 h at 4 °C
and precipitated with protein G–agarose (Pierce). Immunoprecipitates
were washed extensively before immunoblotting or in vitro kinase
assay. Immunoblotting was as described [56]. In vitro kinase assays of
immunoprecipitates were performed in 50 mM Hepes pH 7.5, 10 mM
MgCl2, 100mM ATP and 10mCi [g-32P ]ATP for 10 min at 30 °C with
0.1mgm l–1 MBP as substrate. GTPgS–Cdc42 (2mg) was added to
each 20m l reaction where noted.
The antibodies against the amino-terminal 20 amino acids of Pak1
(used for immunoblotting) and the Myc epitope tag were from Santa
Cruz. The antibody against the HA epitope tag was from Berkeley Anti-
body Co. The anti-Nck antibody for immunoblotting was from Trans-
duction Laboratories. The anti-Nck and Pak1 antibodies for
immunoprecipitation were raised in rabbits immunized with GST fused
to full-length human Nck or GST fused to the amino-terminal 266
residues of human Pak1, and the anti-Nck antibodies were affinity-puri-
fied using immobilized immunogen. 
Activation of MAP kinases
pEBG-Erk1 or pEBG-p38 (4 mg each) was cotransfected with 4mg
other plasmids. Positive control cells were treated with 100 ng ml–1
EGF for 30 min before harvesting; 48 h post-transfection, cells were
lysed in 1 ml ice-cold kinase lysis buffer (25 mM Tris pH 7.4, 150 mM
NaCl, 5 mM EDTA, 1 % Triton X-100, 10 mM sodium pyrophosphate,
10 mM b-glycerophosphate, 1 mM sodium orthovanadate, 10 % glyc-
erol, 1 mM PMSF and 20mg ml–1 aprotinin). GST fusion proteins were
purified from cell lysates by binding to glutathione–agarose beads and
eluted with 50 mM Hepes pH 7.5, 20 mM glutathione, and 10 % glyc-
erol. Purified kinases were normalized by Coomassie blue staining and
in vitro kinase assays were performed with equal amounts of kinase.
Reaction conditions were as above with 0.1mg ml–1 MBP included as
exogenous substrate.
For the inhibition of Erk1 activation by kinase-inactive Pak1, 0.1mg
Src–SH3 plasmid was cotransfected with 4mg pEBG–Erk with or
without 10mg Pak1 mutant plasmid; 24 h after transfection, the cells
were lysed and activity assayed as above.
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